Elevated testosterone levels increase maternal blood pressure and decrease uterine blood flow in pregnancy, resulting in abnormal perinatal outcomes. We tested whether elevated testosterone alters uterine artery adaptations during pregnancy, and if these alterations depend upon endothelium-derived factors such as nitric oxide (NO), endothelium-derived hyperpolarizing factor (EDHF) and prostacyclin, or endothelium-independent mechanisms such as angiotensin II. Pregnant Sprague-Dawley rats were injected with vehicle (n=20) or testosterone propionate (0.5mg/Kg/day from gestation-day 15-19;n=20). Plasma testosterone levels increased 2-fold in testosterone-injected rats compared to controls. Elevated testosterone significantly decreased placental and pup weights compared to controls. In endothelium-intact uterine arteries, contractile responses to thromboxane, phenylephrine and angiotensin II were greater in testosterone-treated rats compared to controls. In endothelium-denuded arteries, contractile responses to angiotensin II (pD2=9.1±0.04 vs. 8.7±0.04 in controls,p<0.05) but not thromboxane and phenylephrine were greater in testosterone-treated rats. Angiotensin II type-1b receptor expression was increased while angiotensin II type-2 receptor was decreased in testosterone-exposed arteries. In endothelium-denuded arteries, relaxations to sodium nitroprusside were unaffected. Endothelium-dependent relaxation to acetylcholine was significantly lower in arteries from testosterone-treated dams (Emax=51.80%±6.9% vs. 91.98%±1.4% in controls,p<0.05). Assessment of endothelial factors showed NO-, EDHF- and prostacyclin-mediated relaxations were blunted in testosterone-treated dams. Endothelial NO-synthase, small conductance calcium-activated potassium channel-3 and prostacyclin receptor expressions were significantly decreased in arteries from testosterone-treated dams. Hypoxia-inducible factor-1α, Ankrd37 and Egln were significantly increased in testosterone-exposed placentae. These results suggest that elevated maternal testosterone impairs uterine vascular function, which may lead to an increased vascular resistance and a decrease in uterine blood flow.